Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
06/30/2005 | CA2549197A1 Methods for producing storage stable viruses and immunogenic compositions thereof |
06/30/2005 | CA2549000A1 Method for treating neurological disorders |
06/30/2005 | CA2548792A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
06/30/2005 | CA2548512A1 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases |
06/30/2005 | CA2548502A1 Methods and compositions relating to ccr5 antagonist, ifn-.gamma. and il-13 induced inflammation |
06/30/2005 | CA2548347A1 Methods for generating immunity to antigen |
06/30/2005 | CA2548338A1 Ip-10 antibodies and their uses |
06/30/2005 | CA2548249A1 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product |
06/30/2005 | CA2547635A1 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
06/30/2005 | CA2547076A1 Pathogenic bovine enterovirus, vaccines, and diagnostic methods |
06/30/2005 | CA2547060A1 Pharmaceutical preparation comprising an antibody against the egf receptor |
06/30/2005 | CA2546054A1 Interferon alpha antibodies and their uses |
06/30/2005 | CA2545671A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
06/29/2005 | EP1548032A1 Kdr peptides and vaccines comprising the same |
06/29/2005 | EP1547612A1 Medicinal agent and method for curing erectile dysfunction |
06/29/2005 | EP1547610A1 Immunotherapy for food allergy by reduced and alkylated food allergens |
06/29/2005 | EP1546731A2 Method for treating or preventing metastasis of colorectal cancers |
06/29/2005 | EP1546730A2 Method for treating or preventing metastasis of colorectal cancers |
06/29/2005 | EP1546727A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
06/29/2005 | EP1546726A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
06/29/2005 | EP1546719A2 Isolation and identification of t cells |
06/29/2005 | EP1546704A2 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
06/29/2005 | EP1546703A2 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
06/29/2005 | EP1546409A2 Method for diagnosing chronic myeloid leukemia |
06/29/2005 | EP1546377A2 Methods and compositions to treat pain and painful disorders using 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002,16209, 314, 636, 27410, 33260, 619,15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 or 13424 molecules |
06/29/2005 | EP1546361A1 Auto-stimulating cells and method for making and using the same |
06/29/2005 | EP1546357A2 Immunogenic mycoplasma hyopneumoniae polypeptides |
06/29/2005 | EP1546341A1 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
06/29/2005 | EP1546324A1 Expression vectors encoding epitopes of target-associated antigens |
06/29/2005 | EP1546310A2 Immunomodulating compositions, processes for their production and uses therefor |
06/29/2005 | EP1546309A2 Animal immunocontraceptives expressed in plants and uses thereof |
06/29/2005 | EP1546308A1 A method of treating an autoimmune disease |
06/29/2005 | EP1546206A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
06/29/2005 | EP1546204A2 Humanized anti-granulocyte mn-3 antibody and uses thereof |
06/29/2005 | EP1546194A2 Therapeutic uspa1-derived peptides |
06/29/2005 | EP1546191A2 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
06/29/2005 | EP1546190A2 Hbv mutations associated with reduced susceptibility to adefovir |
06/29/2005 | EP1546182A2 Compositions and methods for the diagnosis and treatment of tumor |
06/29/2005 | EP1546181A2 Methods of reducing ischemic injury |
06/29/2005 | EP1546175A1 Group b streptococcal phage lysin |
06/29/2005 | EP1546137A1 Benzimidazol-1-yl-thiophene compounds for the treatment of cancer |
06/29/2005 | EP1545625A2 Flexible vaccine assembly and vaccine delivery platform |
06/29/2005 | EP1545616A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
06/29/2005 | EP1545615A2 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists |
06/29/2005 | EP1545614A2 Treatment of pathologies which escape the immune response, using optimised antibodies |
06/29/2005 | EP1545613A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
06/29/2005 | EP1545610A2 Epitope sequences |
06/29/2005 | EP1545607A1 Allergy vaccines |
06/29/2005 | EP1545605A2 Composition for vaccination |
06/29/2005 | EP1545604A2 Use of mullerian inhibiting substance and interferon for treating tumors |
06/29/2005 | EP1545603A2 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
06/29/2005 | EP1545602A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
06/29/2005 | EP1545600A2 Protein and peptide expression for passive immunity |
06/29/2005 | EP1545599A1 Immunogenic compositions and diagnostic and therapeutic uses thereof |
06/29/2005 | EP1545598A2 Formulation of glutamic acid decarboxylase (gad65) and serum albumin |
06/29/2005 | EP1545597A2 Immunostimulatory compositions and methods of stimulating an immune response |
06/29/2005 | EP1545596A2 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
06/29/2005 | EP1545595A2 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
06/29/2005 | EP1545594A1 Bacteriophage-mediated immunisation against hepatitis |
06/29/2005 | EP1545592A1 Combination treatment of cancer using a cancer vaccine and a chemotherapeutic drug |
06/29/2005 | EP1545578A2 Compositions and methods for treating cardiovascular disease |
06/29/2005 | EP1545556A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
06/29/2005 | EP1545507A2 Activated checkpoint therapy and methods of use thereof |
06/29/2005 | EP1545458A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
06/29/2005 | EP1545432A2 Use of excipients to increase dna uptake by swine muscle cells |
06/29/2005 | EP1545430A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
06/29/2005 | EP1545207A2 Treatment of holocrine gland dysfunction with clostridia neurotoxins |
06/29/2005 | EP1545196A2 Prevention of primary sjögren's syndrome by ica69 deficiency |
06/29/2005 | EP1246624B1 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
06/29/2005 | EP1146861B1 Hydrogel particle formulations |
06/29/2005 | EP1119625B1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
06/29/2005 | EP1025216B1 Transgenic animal models for cardiac hypertrophy and uses thereof |
06/29/2005 | EP0914134B1 Adjuvant properties of poly(amidoamine) dendrimers |
06/29/2005 | EP0773957B1 Secreted hepatitis C virus E1/E2 complex obtained from C-terminally truncated E1 and E2 polypeptides |
06/29/2005 | EP0693125B1 Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin |
06/29/2005 | CN1633499A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
06/29/2005 | CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof |
06/29/2005 | CN1633448A Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
06/29/2005 | CN1632124A Gene encoding hemagglutinin protein of H5 avian influenza virus and its application |
06/29/2005 | CN1632116A Enhancement of virus-mediated DNA transfer |
06/29/2005 | CN1632109A Highly expressed recombinant gutted adenovirus containing human constant region whole antibody gene and its use |
06/29/2005 | CN1631896A Recombinant protein |
06/29/2005 | CN1631441A Nucleic acid vaccine for preventing AIDS |
06/29/2005 | CN1631440A Recombined poxvirus vaccine for preventing AIDS |
06/29/2005 | CN1631439A Curtail hemagglutinin vaccine for preventing influenza virus and its preparing method |
06/29/2005 | CN1631438A 0157 bacterium gene engineering multivalence subunit vaccine of human and sensitive animals and its preparing method |
06/29/2005 | CN1208463C Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
06/29/2005 | CN1208450C Method for the purification, recovery, and sporulation of cysts and oocysts |
06/29/2005 | CN1208340C An infections clone for human parainfluenza virus type 3 |
06/29/2005 | CN1208089C Medicine for treating allergic disease and its preparing method |
06/28/2005 | US6911532 Vertebrate apoptosis gene: compositions and methods |
06/28/2005 | US6911527 HIV related peptides |
06/28/2005 | US6911220 Inactivating mature recipient t cells and introducing into a primate recipient fetal or neonatal thymic tissue from a donor of a different species; restoring thymus dependent ability for progenitors to develop into mature t cells |
06/28/2005 | US6911207 Cytotoxic T-cell epitopes of the papillomavirus L1-protein and use thereof in diagnostics and therapy |
06/28/2005 | US6911206 Fusion proteins comprising carriers that can induce a dual immune response |
06/28/2005 | US6911205 Stabilized soluble glycoprotein trimers |
06/28/2005 | CA2101924C Specific peptide sequences of hepatic stage p. falciparum bearing epitopes capable of stimulating t lymphocytes |
06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
06/23/2005 | WO2005056801A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them |
06/23/2005 | WO2005056773A1 Production of diphtheria toxin |